Amyloidosis, other/unspecified

amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.

Endpoint definition

Long name Amyloidosis, other/unspecified
Hospital Discharge registry ICD-10: E859, ICD-8: 27699
Cause of Death registry ICD-10: E859, ICD-8: 27699
Level in the ICD-hierarchy 4
First defined in version DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 180 88 92
Unadjusted prevalence (%) 0.08 0.07 0.10
Mean age at first event (years) 61.15 58.55 63.63
Case fatality at 5-years (%) 20.56 20.45 20.65

Longitudinal metrics

All Female Male
Median nb. of events per indiv. 3.0 4.5 3.0
Recurrence at 6 months (%) 60.56 65.91 55.43

Survival analyses between endpoints


before Amyloidosis, other/unspecified
after Amyloidosis, other/unspecified

Loading survival analyses plot…

Drugs most likely to be purchased after Amyloidosis, other/unspecified